Search Results - "Moran, Andrew E"

Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension Among Young Adults in the United States, 1999 to 2014 by Zhang, Yiyi, Moran, Andrew E

“…Overall hypertension prevalence has not changed in the United States in recent decades although awareness, treatment, and control improved. However,…”
Get full text

Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010 by Feigin, Valery L, Prof, Forouzanfar, Mohammad H, Prof, Krishnamurthi, Rita, PhD, Mensah, George A, MD, Connor, Myles, MBBCh, Bennett, Derrick A, PhD, Moran, Andrew E, Prof, Sacco, Ralph L, Prof, Anderson, Laurie, Prof, Truelsen, Thomas, MD, O'Donnell, Martin, Prof, Venketasubramanian, Narayanaswamy, MBBS, Barker-Collo, Suzanne, Prof, Lawes, Carlene M M, MBChB, Wang, Wenzhi, Prof, Shinohara, Yukito, MD, Witt, Emma, MSc, Ezzati, Majid, Prof, Naghavi, Mohsen, Prof, Murray, Christopher, Prof

“…Summary Background Although stroke is the second leading cause of death worldwide, no comprehensive and comparable assessment of incidence, prevalence,…”
Get full text

Global and Regional Patterns in Cardiovascular Mortality From 1990 to 2013 by Roth, Gregory A, Huffman, Mark D, Moran, Andrew E, Feigin, Valery, Mensah, George A, Naghavi, Mohsen, Murray, Christopher J.L

“…There is a global commitment to reduce premature cardiovascular diseases (CVDs) 25% by 2025. CVD mortality rates have declined dramatically over the past 2…”
Get full text

Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality by Roth, Gregory A, Forouzanfar, Mohammad H, Moran, Andrew E, Barber, Ryan, Nguyen, Grant, Feigin, Valery L, Naghavi, Mohsen, Mensah, George A, Murray, Christopher J.L

“…According to the Global Burden of Disease Study, between 1990 and 2013, global cardiovascular mortality increased by 55% as a result of aging and by 25% as a…”
Get full text

Projected Impact of Mexico's Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study by Sánchez-Romero, Luz Maria, Penko, Joanne, Coxson, Pamela G, Fernández, Alicia, Mason, Antoinette, Moran, Andrew E, Ávila-Burgos, Leticia, Odden, Michelle, Barquera, Simón, Bibbins-Domingo, Kirsten

“…Rates of diabetes in Mexico are among the highest worldwide. In 2014, Mexico instituted a nationwide tax on sugar-sweetened beverages (SSBs) in order to reduce…”
Get full text

Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease by Barquera, Simon, Pedroza-Tobías, Andrea, Medina, Catalina, Hernández-Barrera, Lucía, Bibbins-Domingo, Kirsten, Lozano, Rafael, Moran, Andrew E

“…Atherosclerotic cardiovascular disease (ACD) is the leading cause of mortality worldwide. The objective of this paper is to provide an overview of the global…”
Get full text

Spending on Cardiovascular Disease and Cardiovascular Risk Factors in the United States: 1996 to 2016 by Birger, Maxwell, Kaldjian, Alexander S, Roth, Gregory A, Moran, Andrew E, Dieleman, Joseph L, Bellows, Brandon K

“…Spending on cardiovascular disease and cardiovascular risk factors (cardiovascular spending) accounts for a significant portion of overall US health care…”
Get full text

Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations by Gotanda, Hiroshi, Liyanage-Don, Nadia, Moran, Andrew E., Krousel-Wood, Marie, Green, Jonas B., Zhang, Yiyi, Nuckols, Teryl K.

“…The COVID-19 pandemic may have negatively affected medical care for and self-management of chronic hypertension. We sought to examine the impact of the…”
Get full text

Young Adult Exposure to Cardiovascular Risk Factors and Risk of Events Later in Life: The Framingham Offspring Study by Pletcher, Mark J, Vittinghoff, Eric, Thanataveerat, Anusorn, Bibbins-Domingo, Kirsten, Moran, Andrew E

“…It is unclear whether coronary heart disease (CHD) risk factor exposure during early adulthood contributes to CHD risk later in life. Our objective was to…”
Get full text

Physical activity from young adulthood to middle age and premature cardiovascular disease events: a 30-year population-based cohort study by Nagata, Jason M, Vittinghoff, Eric, Gabriel, Kelley Pettee, Rana, Jamal S, Garber, Andrea K, Moran, Andrew E, Reis, Jared P, Lewis, Cora E, Sidney, Stephen, Bibbins-Domingo, Kirsten

“…Abstract Background Although physical activity is generally protective of cardiovascular disease (CVD), less is known about how young adult physical activity…”
Get full text

Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group by Gooding, Holly C, Gidding, Samuel S, Moran, Andrew E, Redmond, Nicole, Allen, Norrina B, Bacha, Fida, Burns, Trudy L, Catov, Janet M, Grandner, Michael A, Harris, Kathleen Mullan, Johnson, Heather M, Kiernan, Michaela, Lewis, Tené T, Matthews, Karen A, Monaghan, Maureen, Robinson, Jennifer G, Tate, Deborah, Bibbins-Domingo, Kirsten, Spring, Bonnie

“…Improvements in cardiovascular disease (CVD) rates among young adults in the past 2 decades have been offset by increasing racial/ethnic and gender…”
Get full text

The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study by Gu, Dongfeng, He, Jiang, Coxson, Pamela G, Rasmussen, Petra W, Huang, Chen, Thanataveerat, Anusorn, Tzong, Keane Y, Xiong, Juyang, Wang, Miao, Zhao, Dong, Goldman, Lee, Moran, Andrew E

“…Hypertension is China's leading cardiovascular disease risk factor. Improved hypertension control in China would result in result in enormous health gains in…”
Get full text

A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries by Huffman, Mark D, Rao, Krishna D, Pichon-Riviere, Andres, Zhao, Dong, Harikrishnan, S, Ramaiya, Kaushik, Ajay, V S, Goenka, Shifalika, Calcagno, Juan I, Caporale, Joaquín E, Niu, Shaoli, Li, Yan, Liu, Jing, Thankappan, K R, Daivadanam, Meena, van Esch, Jan, Murphy, Adrianna, Moran, Andrew E, Gaziano, Thomas A, Suhrcke, Marc, Reddy, K Srinath, Leeder, Stephen, Prabhakaran, Dorairaj

“…To estimate individual and household economic impact of cardiovascular disease (CVD) in selected low- and middle-income countries (LMIC). Empirical evidence on…”
Get full text

Facilitators and barriers of the implementation of point-of-care devices for cardiometabolic diseases: a scoping review by Tenorio-Mucha, Janeth, Busta-Flores, Patricia, Lazo-Porras, María, Vetter, Beatrice, Safary, Elvis, Moran, Andrew E, Gupta, Reena, Bernabé-Ortiz, Antonio

“…Point-of-care testing (POCT) devices may facilitate the delivery of rapid and timely results, providing a clinically important advantage in patient management…”
Get full text

Cardiovascular Risk Assessment by Pletcher, Mark J., MD, MPH, Moran, Andrew E., MD, MPH

“…Cardiovascular risk assessment is fundamental to prevention of cardiovascular disease, because it helps determine the size of the potential benefits that might…”
Get full text

Quality Improvement for Cardiovascular Disease Care in Low- and Middle-Income Countries: A Systematic Review by Lee, Edward S, Vedanthan, Rajesh, Jeemon, Panniyammakal, Kamano, Jemima H, Kudesia, Preeti, Rajan, Vikram, Engelgau, Michael, Moran, Andrew E

“…The majority of global cardiovascular disease (CVD) burden falls on people living in low- and middle-income countries (LMICs). In order to reduce preventable…”
Get full text

HEARTS in the Americas: saving lives from the world’s deadliest disease by Frieden, Thomas R., Moran, Andrew E., Garg, Renu

Get full text

Leveraging Telemedicine for Chronic Disease Management in Low- and Middle-Income Countries During Covid-19 by Hoffer-Hawlik, Michael A, Moran, Andrew E, Burka, Daniel, Kaur, Prabhdeep, Cai, Jun, Frieden, Thomas R, Gupta, Reena

“…In response to the Covid-19 pandemic, many low- and middle-income countries (LMICs) expanded access to telemedicine to maintain essential health services…”
Get full text

Cost of primary care approaches for hypertension management and risk-based cardiovascular disease prevention in Bangladesh: a HEARTS costing tool application by Husain, Muhammad Jami, Haider, Mohammad Sabbir, Tarannum, Renesa, Jubayer, Shamim, Bhuiyan, Mahfuzur Rahman, Kostova, Deliana, Moran, Andrew E, Choudhury, Sohel Reza

“…ObjectiveTo estimate the costs of scaling up the HEARTS pilot project for hypertension management and risk-based cardiovascular disease (CVD) prevention at the…”
Get full text

Recurrent Atherosclerotic Cardiovascular Event Rates Differ Among Patients Meeting the Very High Risk Definition According to Age, Sex, Race/Ethnicity, and Socioeconomic Status by An, Jaejin, Zhang, Yiyi, Muntner, Paul, Moran, Andrew E, Hsu, Jin-Wen, Reynolds, Kristi

“…Background The risk for atherosclerotic cardiovascular disease (ASCVD) events may differ by sociodemographic factors among patients meeting the definition of…”
Get full text